The Global Medtech Industry: Rewiring Medtech in a Post-Pandemic World
The medtech industry is undergoing rapid change to address evolving global market dynamics. This has been further accelerated by the pandemic. This white paper from IQVIA – an associate member of AdvaMed – discusses how global markets and specific therapeutic areas are poised for growth over the next decade. Read this white paper to help inform business strategy.
Related Reading
Resource / Global & Trade / Supply Chain
EY 18th annual Pulse of the MedTech Industry Report
October 25, 2024
The 18th annual Pulse of the MedTech Industry report finds the medical technology industry continuing to push at new frontiers, as ongoing breakthroughs in MedTech AI and renewed hope for MedTech M&A hold out the possibility of making devices smarter, smaller and more personalized.
News / Global & Trade
AdvaMed Welcomes India, New Member Countries from Latin America, Middle East, Africa to IMDRF
October 10, 2024
The International Medical Device Regulators Forum (IMDRF) consists of medical device regulators from around the world that voluntarily convene to harmonize the regulatory requirements for medical products varying from country to country. The U.S. FDA is the Chair and Secretariat of the IMDRF for 2024 and recently hosted its 26th session. The IMDRF added 15 new affiliate members this year (Botswana, Costa Rica, Dominican Republic, El Salvador, Ethiopia, Kenya, India, Jordan, México, Oman, Nigeria, Paraguay, Peru, Tanzania, and Zimbabwe).
News / Code of Ethics / Global & Trade
AdvaMed Welcomes APEC Recommendations for Enterprise Integrity and Public Procurement
September 23, 2024
News / Global & Trade
AdvaMed Signs New MOU with British Medtech Association
June 26, 2024
AdvaMed, the Medtech Association, signed a renewed memorandum of understanding with the Association of British HealthTech Industries (ABHI) to strengthen the relationship between two of the leading medtech organizations in the world.
News / Global & Trade
AdvaMed Statement on FDA-USAID India Regulatory Session
April 16, 2024
AdvaMed, the Medtech Association, released the following statement thanking the FDA Center for Radiological Health (CDRH) for recently hosting an event in New Delhi to discuss regulatory policies and best practices for ensuring medical technology reaches patients. The event, called “Minds to Markets: Regulatory Considerations in Med-Tech,” advances US-India cooperation on medtech supply chain through greater regulatory alignment.
News / Global & Trade
AdvaMed Statement on the World Trade Organization Ministerial Conference
March 1, 2024
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker regarding the conclusion of the World Trade Organization Ministerial conference in Abu Dhabi.
News / Global & Trade / Medical Imaging
AdvaMed Statement on the Sale and Privatization of the Federal Helium Reserve
January 22, 2024
Scott Whitaker, President and CEO of AdvaMed, the Medtech Association, urged the White House to delay the sale and privatization of the Federal Helium Reserve until concerns about resulting supply chain disruptions are resolved.
News / Global & Trade
AdvaMed Statement on 14th Ministerial Meeting of the United States-India Trade Policy Forum
January 19, 2024
AdvaMed President and CEO Scott Whitaker released the following statement regarding the 14th Ministerial-level Trade Policy Forum held in New Delhi, India: